BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
NEUROG3
,
Response to oxidative stress
,
Arthritis
,
Lymphocyte
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
E- cadherin
Summary
General Info
Curated Studies
Most Correlated Studies
Breast cancer cell lines overexpressing E-cadherin
Embryonic stem cells with E-cadherin replaced with N-cadherin
Mammary epithelial cells MCF10A knockout for E-cadherin compared to wildtype
E-cadherin high and low subsets in SCC9 and OCTT2 head and neck squamous cell carcinoma
MDCK kidney epithelial cells overexpressing the E-cadherin transcriptional repressor E2-2
Explore Curated Studies Results
Literature
Most Relevant Literature
Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin.
Reversible photoregulation of cell-cell adhesions with opto-E-cadherin.
E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer.
Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells.
Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveoli…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-prot…
The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis
The Gastric Cancer Foundation: A Gastric Cancer Registry
Epithelial Mesenchymal Transition Markers in OSMF
Biomarkers Predicting Response in Patients With Non-Small Cell Lung Cancer Previously Treated With E…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ